z-logo
open-access-imgOpen Access
CSIG-09. ERK1/2-DRIVEN SPROUTY2 EXPRESSION MEDIATES RESISTANCE TO RECEPTOR TYROSINE KINASE-TARGETED THERAPEUTICS IN GLIOBLASTOMA CELLS
Author(s) -
Evan K. Day,
Matthew J. Lazzara
Publication year - 2016
Publication title -
neuro-oncology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 4.005
H-Index - 125
eISSN - 1523-5866
pISSN - 1522-8517
DOI - 10.1093/neuonc/now212.170
Subject(s) - receptor tyrosine kinase , cancer research , mapk/erk pathway , kinase , biology , signal transduction , phosphorylation , carcinogenesis , microbiology and biotechnology , cancer , genetics

The content you want is available to Zendy users.

Already have an account? Click here to sign in.
Having issues? You can contact us here
Accelerating Research

Address

John Eccles House
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom